Evaluation of the Effect of Sildenafil and Vascular Endothelium Growth Factor Combination Treatment on Skin Flap Survival in Rats

被引:0
作者
John W. Tsai
Farhan S. Ayubi
Kristopher L. Hart
Dale A. Baur
Mary A. Parham
Jay K. Moon
Raymond Vazquez
Arthur B. Chasen
Zhuo Zhang
Jose M. Pizarro
机构
[1] Dwight David Eisenhower Army Medical Center,Department of General Surgery
[2] Darnall Army Medical Center,Department of Oral and Maxillofacial Surgery
[3] University Hospitals at Case Medical Center,Department of Oral and Maxillofacial Surgery
[4] Dwight David Eisenhower Army Medical Center,Department of Clinical Investigation
[5] Tripler Army Medical Center,Department of Clinical Investigation
来源
Aesthetic Plastic Surgery | 2008年 / 32卷
关键词
VEGF; Sildenafil; Skin flap; Rat;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:624 / 631
页数:7
相关论文
共 137 条
[1]  
Vural E(2001)Complications, salvage, and enhancement of local flaps in facial reconstruction Otolaryngol Clin North Am 34 739-751
[2]  
Key JM(1996)Dependence of tissue oxygen on oxygen delivery J Surg Res 61 201-205
[3]  
Slate RK(2004)The effect of replacement fluids and normovolaemic haemodilution on the survival of dorsal skin flaps in rats Clin Otolaryngol Allied Sci 29 80-83
[4]  
Ryan M(1970)Pedicled skin-flaps: the fallacy of the length:width ratio Br J Surg 57 502-508
[5]  
Bongard FS(2006)Short- and long-term effects of sildenafil on skin flap survival in rats Laryngoscope 116 522-528
[6]  
Tuz M(2003)Reliable assessment of skin flap viability using orthogonal polarization imaging Plast Reconstr Surg 112 547-555
[7]  
Eroglu E(1992)When does a random flap die? Plast Reconstr Surg 89 718-721
[8]  
Dogru H(1999)cGMP and cAMP cause pulmonary vasoconstriction in the presence of hemolysate J Appl Physiol 86 1715-1720
[9]  
Delibas N(1995)Nitric oxide-related vasoconstriction in lungs perfused with red cell lysate FASEB J 9 379-386
[10]  
Tunc B(2006)Sildenafil induces angiogenic response in human coronary arteriolar endothelial cells through the expression of thioredoxin, hemeoxygenase and vascular endothelial growth factor Vascul Pharmacol 45 91-95